A large number of studies have shown that the adaptor protein MyD88 contributes to carcinogenesis, including cancer of the skin, liver, pancreas, and colon, by acting downstream of Toll-like receptors (TLRs) or the IL1 family [39]. Here, MYD88 is linked to skin neoplasm.